Succimer
CAS No. 304-55-2
Succimer( Succimer | DMSA )
Catalog No. M13963 CAS No. 304-55-2
Succimer is a Lead Chelator. The mechanism of action of succimer is as a Lead Chelating Activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 37 | In Stock |
|
| 1G | 52 | In Stock |
|
Biological Information
-
Product NameSuccimer
-
NoteResearch use only, not for human use.
-
Brief DescriptionSuccimer is a Lead Chelator. The mechanism of action of succimer is as a Lead Chelating Activity.
-
DescriptionSuccimer is a Lead Chelator. The mechanism of action of succimer is as a Lead Chelating Activity.(In Vivo):Succimer is a widely used chelating agent for the treatment of Pb poisoning. Red blood cells (RBCs) from lead exposed animals treated with NAC or Succimer are shown to have significantly higher glutathione (GSH) levels and diminished malondialdehyde (MDA) levels when compare to the lead group. Succimer administration also results in decreased glucose 6-phosphate dehydrogenase (G6PD) activity in RBCs from lead exposed animals. Succimer treatment produces a significant reduction in blood lead levels for both lead exposure conditions: the High Pb-succ group has blood lead levels that are 27% of the blood lead levels of the High Pb group at the end of treatment. Succimer is effective in substantially reducing brain lead, as brain lead levels in the High Pb-succ group are 37% of levels in the High Pb group.
-
In Vitro——
-
In VivoSuccimer is a widely used chelating agent for the treatment of Pb poisoning. Red blood cells (RBCs) from lead exposed animals treated with NAC or Succimer are shown to have significantly higher glutathione (GSH) levels and diminished malondialdehyde (MDA) levels when compare to the lead group. Succimer administration also results in decreased glucose 6-phosphate dehydrogenase (G6PD) activity in RBCs from lead exposed animals. Succimer treatment produces a significant reduction in blood lead levels for both lead exposure conditions: the High Pb-succ group has blood lead levels that are 27% of the blood lead levels of the High Pb group at the end of treatment. Succimer is effective in substantially reducing brain lead, as brain lead levels in the High Pb-succ group are 37% of levels in the High Pb group.
-
SynonymsSuccimer | DMSA
-
PathwayOthers
-
TargetOther Targets
-
RecptorCadmium| Lead| Mercury| Others
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number304-55-2
-
Formula Weight182.22
-
Molecular FormulaC4H6O4S2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO=C(O)[C@@H](S)[C@@H](S)C(O)=O
-
Chemical Namemeso-2,3-Dimercaptosuccinic acid;
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Amyloid β-Protein (4...
Amyloid β-Protein (4-42) is aAβ Fragment.
-
Cltrinin
Citrinin (NSC 186) is a mycotoxin that causes food contamination and has different toxic effects. Citrinin is an effective oral anticancer agent. Citrinin has various regulatory effects on mouse immune system, including regulating the number of immune cells, inducing apoptosis and autophagy of immune cells, altering toll-like receptor expression and cytokine production. Citrinin can induce oxidative stress and lead to early apoptosis of oocytes. Low doses of Citrinin have neuroprotective effects against glutamate-induced excitotoxicity in rat cortical neurons. In addition, Citrinin also has antibacterial activity.
-
Pyridoxal 5-phosphat...
Pyridoxal 5-phosphate monohydrate is an active vitamin B6 metabolite.
Cart
sales@molnova.com